3 results  1 of 1 

1 Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice
Qian Zhu, Qu Zhou, Xiao-li Luo, Xu-jie Zhang, San-yu Li
Korean J Physiol Pharmacol.2023;27(3):221-230.   Published online 2023 May 1     DOI: http://dx.doi.org/10.4196/kjpp.2023.27.3.221
      
2 Prevention of Major Adverse Cardiovascular and Renal Outcomes with Sodium-Glucose Cotransporter 2 Inhibitors
Jun Hwa Hong
J Korean Diabetes.2019;20(2):87-91.   Published online 2019 June 30     DOI: http://dx.doi.org/10.4093/jkd.2019.20.2.87
      
3 A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor
Chang Hee Jung, Jung Eun Jang, Joong-Yeol Park
Diabetes Metab J.2014;38(4):261-273.   Published online 2014 August 20     DOI: http://dx.doi.org/10.4093/dmj.2014.38.4.261
      

 1 of 1